Recon Therapeutics has developed The LyoKit Disposable Reconstitution System, a new patent-pending drug delivery technology that simplifies patient self-administration of biologic drugs. The LyoKit System is novel because it does not reinvent the syringe; instead, it couples a standard 3mL syringe with an external pressurized water chamber, resulting in a simple one-step reconstitution process.
Please visit: www.recontherapeutics.com for more information.
Company Details
- Employees
- 1
- Founded
- -
- Industry
- Biotechnology
- Website
- recontherapeutics.com
- Keywords
- NextGen Venture Partners.
Recon Therapeutics Questions
Recon Therapeutics's website is recontherapeutics.com
Recon Therapeutics's LinkedIn profile is https://www.linkedin.com/company/recon-therapeutics
Recon Therapeutics has
1 employees.
View email and phone details for 1
employees at Recon Therapeutics.
Recon Therapeutics's industry is
Biotechnology
Recon Therapeutics's top competitors are
Nextgen Venture Partners,
Akita Biosciences,
Fourier Health,
Despierta,
Scivida,
Dxlab Inc..
Recon Therapeutics's categories are Biotechnology
Recon Therapeutics's founding year is 2014
